Skip to content
IP Infusion logo — Accelerating Network Disaggregation for Service Provider and...

IP Infusion

Accelerating Network Disaggregation for Service Provider and Data Centers.

Founded 1999 United States Santa Clara, United States 501 employees Series C Total: $16.70M Hardware, ISP

General Information

Company Name IP Infusion
Founded Year 1999
Location United States Santa Clara, United States
Employees 501
Industries Hardware, ISP
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with IP Infusion. To contact IP Infusion, visit ipinfusion.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does IP Infusion compare?

A PDF of IP Infusion and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting IP Infusion soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About IP Infusion

IP Infusion is a network software company based in Santa Clara, Calif., that focuses on accelerating network disaggregation for service providers and data centers. Established in 1999, the company provides network OS solutions to over 300 customers, enabling them to reduce network costs, enhance flexibility, and rapidly deploy new features and services. Their flagship products include the OcNOS® and ZebOS® network operating systems, and they also serve as an integrator and customer service provider for DANOS-Vyatta edition. The company recently secured a significant $14.70M Series C investment on 19 April 2002, with notable investors including Blumberg Capital, Neoteny, Intel Capital, Akers Capital, IT-Farm, ITX International Holdings, Formative Ventures, Pete Thomas, imGO, and Bill Tai. With a strong focus on the ISP industry, IP Infusion continues to drive innovation in network disaggregation and is positioned well for growth. For more information, visit their website at http://www.ipinfusion.com.

Business keywords: network disaggregation, service providers, data centers, network OS solutions, OcNOS, ZebOS, DANOS-Vyatta edition, Santa Clara, ACCESS CO., LTD, carrier-grade networking, customer service provider, network flexibility, network cost reduction, network deployment

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $14.70M 10
Blumberg Capital, Neoteny +8
19 Apr 2002
Series B $2.00M -
01 Feb 2000

IP Infusion Alternatives & Competitors

IP Infusion vs
Ekinops
Ekinops France

Empowering Networks: open, trusted and innovative network connectivity for telecom service providers...

Grant
464 employees
Hardware, ISP

FAQ About IP Infusion

Accelerating Network Disaggregation for Service Provider and Data Centers.
IP Infusion was founded in 1999.
IP Infusion is headquartered in Santa Clara, United States.
IP Infusion operates in Hardware and ISP. Its work centres on network disaggregation, service providers, data centers and network OS solutions.
IP Infusion has approximately 501 employees.
IP Infusion has completed 2 funding rounds, raising a total of $16.70M. The latest funding stage is Series C.
Top alternatives and competitors to IP Infusion include Ekinops. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IP Infusion and Ekinops are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for IP Infusion, https://www.bouncewatch.com/company/ip-infusion, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout